Skip to main content
. Author manuscript; available in PMC: 2020 Oct 15.
Published in final edited form as: Clin Cancer Res. 2020 Mar 5;26(8):1915–1923. doi: 10.1158/1078-0432.CCR-19-2659

Table 1:

Summary of clinicopathologic features of the whole dataset.

Variable Subvariables Fraction (%) or mean (STD)

Number of Patients Total 334
Training 127 (38%)
Validation 207 (62%)

Age in years 59.54 (7.15)

Race African-American (AA) 170 (51%)
Caucasian-American (CA) 164 (49%)

Preoperative PSA(ng/mL) Recurrence 10.95 (11.37)
Non-Recurrence 7.92 (11.52)

Pathological Gleason Grade sum 6 or less 109 (33%)
7 197 (59%)
8 or greater 28 (8%)

Pathological Stage T2x 170 (51%)
T3x 94 (28%)
Data not available (either T2x or T3x) 70 (21%)

Time to event (days) Recurrence 1063 (1120)
Last follow-up (Non-Recurrence) 1717 (1411)